“Adaptive pathways is a conceptual approach to developing drugs, to licence them, to reimburse them and to use them in the market place.” – Professor Hans-Georg Eichler

IMI’s ADAPT SMART project is now well into its second year of work to create a functioning, multi-stakeholder environment to implement Medicines Adaptive Pathways for Patients (MAPPs) in Europe. One thing that makes ADAPT SMART unique is that the European Medicines Agency (EMA) is leading the project. In this podcast Professor Hans-Georg Eichler explains the evolution of MAPPs in Europe and Internationally.